PGNY vs VMD: stock comparison and AI forecast
Progyny, Inc. (PGNY) and Viemed Healthcare, Inc. (VMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PGNY Progyny, Inc.
- Market Cap
- $2.64B
- P/E Ratio
- 41.9x
- Size
- mid-cap
- AI Forecast
VMD Viemed Healthcare, Inc.
- Market Cap
- $343M
- P/E Ratio
- 23.1x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- PGNY is 7.7 times larger than VMD by market capitalization ($2.64B against $343M).
- VMD trades at 23.1 times trailing earnings, PGNY at 41.9 times.
- PGNY turns 6.8% of its revenue into net income, against 5.0% for VMD.
- PGNY carries 0.63 times debt per unit of equity, against 0.37 times for VMD.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PGNY | VMD |
|---|---|---|
| Market Cap | $2.64B | $343M |
| P/E Ratio | 41.91x | 23.10x |
| P/B Ratio | 6.37x | 2.29x |
| EPS | $0.82 | $0.39 |
| Book Value/Share | $5.40 | $3.94 |
| Revenue/Share | $17.45 | $8.15 |
| FCF/Share | $2.34 | $0.56 |
Profitability & Margins
| Metric | PGNY | VMD |
|---|---|---|
| ROE | 22.0% | 10.4% |
| ROA | 13.5% | 7.5% |
| ROIC | 28.9% | 15.0% |
| Gross Margin | 24.9% | 57.4% |
| Operating Margin | 9.4% | 7.8% |
| Net Margin | 6.8% | 5.0% |
| EBT Margin | 9.9% | 7.4% |
| Tax Rate | 31.2% | 29.2% |
Financial Health
| Metric | PGNY | VMD |
|---|---|---|
| Current Ratio | 1.93x | 1.25x |
| Quick Ratio | – | 1.16x |
| D/E Ratio | 0.63x | 0.37x |
| Financial Leverage | 1.63x | 1.38x |
| Interest Coverage | 29.3x | 59.0x |
| Working Capital | $224M | $12M |
Cash Flow
| Metric | PGNY | VMD |
|---|---|---|
| Operating Cash Flow | $207M | $54M |
| Free Cash Flow | $180M | $21M |
| Capital Spending | -$28M | -$33M |
| OCF Growth YoY | -0.5% | 11.2% |
| FCF Growth YoY | -7.2% | 296.9% |
| FCF/Sales | 13.4% | 6.9% |
| CapEx/Sales | 2.1% | 10.5% |
Operational Efficiency
| Metric | PGNY | VMD |
|---|---|---|
| Asset Turnover | 1.98x | 1.49x |
| Receivables Turnover | 5.4x | 8.9x |
| Inventory Turnover | – | 29.0x |
| Fixed Assets Turnover | 26.6x | 4.1x |
| Days Sales Outstanding | 68 days | 41 days |
| Days Inventory | – | 13 days |
| Payables Period | 54 days | – |
Income Statement
| Metric | PGNY | VMD |
|---|---|---|
| Total Revenue | $1.34B | $310M |
| Operating Income | $126M | $24M |
| Net Income | $91M | $16M |
| R&D Expense | $16M | $2M |
| SG&A Expense | $362M | $140M |
| Cost of Goods Sold | $1.01B | $132M |
Dividend & Shareholder Information
| Metric | PGNY | VMD |
|---|---|---|
| Shares Outstanding | 77M | 38M |
| Net Income Growth | 60.9% | 14.8% |
| EPS Growth | 34.4% | 44.4% |
PGNY vs VMD: stock comparison and AI forecast
Which is bigger, PGNY or VMD?
PGNY is 7.7 times larger than VMD by market capitalization ($2.64B against $343M).
Which is cheaper on earnings, PGNY or VMD?
VMD trades at 23.1 times trailing earnings, PGNY at 41.9 times.
Which one does Intratio's AI model rank higher, PGNY or VMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.